Hemispherian Initiates Phase 1/2a Trial of GLIX1 in Glioblastoma
08 Apr 2026 //
BUSINESSWIRE
BioNTech to wind up Singapore vaccine plant by early 2027
08 Apr 2026 //
STRAITSTIMES
Novo Nordisk launches higher-dose Wegovy in the United States
08 Apr 2026 //
PRNEWSWIRE
Sanofi’s lunsekimig met primary and key secondary endpoints
08 Apr 2026 //
PRESS RELEASE
FDA Seeks Expand Authority To Regulate Postapproval Manufacturing
08 Apr 2026 //
FDA
Gilead to buy Germany`s Tubulis for up to $5 billion
08 Apr 2026 //
PRESS RELEASE
Biocon Rolls Out Two Biosimilars In US Market
08 Apr 2026 //
ECONOMICTIMES
Insmed Provides Clinical Update On Phase 2B CEDAR Study
08 Apr 2026 //
PR NEWSWIRE
Lupin Gets FDA Approval For Dapagliflozin Tablets In US
08 Apr 2026 //
PR NEWSWIRE
Drugs In Development
Market Intel

Market Place
Sourcing Support